Searched for
MANKIND PHARMA NET PROFIT DROP
Battery recycler BatX Energies raises Rs 105 crore from IvyCap Ventures, othersBatX Energies has secured Rs 105 crore in a funding round led by IvyCap Ventures, with participation from existing investors. The startup s...
Foreign inflows, lower oil prices help Indian bond traders look past US Treasury selloffIndian government bonds saw gains early Thursday, defying a rise in U.S. Treasury yields. This positive movement was fueled by falling oil ...
From deep correction to fresh peaks: 10 stocks soar from 52-week lows to new highs in just three monthsSeveral large-cap Indian companies have seen their stock prices surge from 52-week lows to highs within just three months. This impressive ...
Mankind Pharma partners Denovo Sciences for AI-led drug discoveryMankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...
Uber-backed Lime rides IPO wave to $1.73 billion valuation in Nasdaq debutThe market for new listings has regained momentum after a bout of volatility triggered by the Iran conflict, with companies reviving IPO p...
Uber-backed Lime rides IPO wave to $1.73 billion valuation in Nasdaq debutUber-backed Lime jumped 8% in its Nasdaq debut, valuing the e-scooter and bike rental company at $1.73 billion. The IPO reflects renewed in...
Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
KPIT Tech shares sink 17%, see worst plunge since 2020 Covid crash. Time to buy or more pain ahead?KPIT Technologies shares dropped to a fresh 52-week low on Wednesday after the company warned of weaker-than-expected Q1 FY27 revenue and m...
Why KPIT Tech shares crashed 17% today: The BMW & Volkswagen connection explainedKPIT Technologies witnessed a significant 17% stock plunge following a revenue slowdown warning for Q1FY27, primarily due to unexpected cut...
KPIT Tech shares crash 17% as company expects Q1 revenue decline, sharp hit to marginsKPIT Technologies shares plunged 17% after the company warned of a revenue drop in Q1 FY27, citing unexpected actions from European automak...
Saksoft shares rally 50% in one week. Here's what technical charts indicateSaksoft shares experienced a significant surge, climbing over 14% on Tuesday and an impressive 50% in a single week. This rally follows a d...
Fidelity Investments buys 2 pc stake in Lodha Developers for Rs 1,864 croreFidelity Investments has strategically acquired a 2% stake in Lodha Developers, amounting to Rs 1,864 crore, through open market operations...
India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
Axis Bank aims to strike optimal balance between growth and margins: MDAxis Bank is poised for industry-leading growth while balancing profitability, according to MD and CEO Amitabh Chaudhry. Despite a dip in n...
Largecaps lead profit growth, mid & smallcaps outshine in revenue momentum in Q4Large companies saw stronger net profit growth for the March 2026 quarter, driven by one-off gains, despite slower revenue expansion and wi...
Tech-Led global selloff, Fed rate fears weigh on Indian equitiesIndian stock markets experienced their sharpest single-day drop in nearly a month, mirroring a global tech sell-off. The Nifty 50 and BSE S...
Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
Tata Capital shares slip 3% after stock rallies 17% in one week to lifetime high. What’s ahead?Tata Capital shares saw a dip on Monday following a significant rally that propelled them to an all-time high last week. Despite a recent s...
Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...